...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What if...?
5
Dec 12, 2015 09:41AM
1
Dec 12, 2015 10:07AM

Not really but I'm not sure what you are asking me? Can you elaborate?

4
Dec 12, 2015 11:43AM
1
Dec 12, 2015 11:59AM
5
Dec 12, 2015 12:38PM
Share
New Message
Please login to post a reply